Mr. Ricci
Investor Relations, LifeSci Advisors
Replay available
Relmada Therapeutics, Inc. (RLMD) Q1 2026 Earnings Call
Relmada Therapeutics, Inc. (NASDAQ: RLMD) Q1 2026 earnings conference call, held 2026-05-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Sergio Traversa
Chief Executive Officer
Dr. Raj Pruthi
Chief Medical Officer, Urology
Maggie Chinata
Chief Financial Officer
Kelsey Goldwyn
Analyst, Piper Sandler
Christopher Lu
Analyst, Lucid Capital Markets
Farzin Haque
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Relmada Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:01.803 -- 00:00:06.790 Good afternoon and welcome to Realmada Therapeutics' first quarter earnings conference 00:00:06.790 -- 00:00:11.778 call. At this time, all participants are in a listen-only mode. 00:00:11.778 -- 00:00:16.485 After the prepared remarks, we'll conduct a question-and-answer session. 00:00:16.485 -- 00:00:21.693 To ask a question, please press star 1. As a reminder, this conference call 00:00:21.693 -- 00:00:27.742 is being recorded and will be available for replay on the Realmada website. 00:00:27.742 -- 00:00:32.178 I would now like to turn the call over to Brian Ritchie from Realmada. 00:00:32.178 -- 00:00:37.282 LifeSci advisors, please go ahead, Mr. Ricci. 00:00:37.484 -- 00:00:41.509 Thank you. Good day, everyone, and thank you for joining us today. 00:00:41.509 -- 00:00:46.454 This afternoon, Ramada issued a press release providing a business update and outlining 00:00:46.454 -- 00:00:51.340 its financial results for the three months ended March 31st, 2026. 00:00:51.340 -- 00:00:55.905 Please note that certain information discussed on the call today is covered under the 00:00:55.905 -- 00:01:00.376 safe harbor provision of the Private Securities Litigation Reform Act. 00:01:00.376 -- 00:01:05.622 We caution listeners that during today's call, Real Modest management team will be making 00:01:05.622 -- 00:01:07.925 forward-looking statements. 00:01:07.925 -- 00:01:12.791 Actual results could differ materially from those stated or implied by these forward-looking 00:01:12.791 -- 00:01:18.418 statements due to risks and uncertainties associated with the company's business. 00:01:18.418 -- 00:01:23.014 These forward-looking statements are qualified by the cautionary statements contained 00:01:23.014 -- 00:01:28.342 in RoMATA's press...